Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 4, 1999, Pages 1692-1697

  Gomeza, Jesus ^a   Shannon, Harlan ^b   Kostenis, Evi ^a   Felder, Christian ^b   Zhang, Lu ^b   Brodkin, Jesse ^b   Grinberg, Alexander ^c   Sheng, Hui ^c   Wess, Jürgen ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC M2 RECEPTOR; OXOTREMORINE;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; FEMALE; HYPOTHERMIA; LOCOMOTION; MALE; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; SALIVATION; THERMOREGULATION; TREMOR;

ANALGESIA; ANIMALS; BRAIN; EMBRYO; FEMALE; GENE EXPRESSION; GENOMIC LIBRARY; HOMOZYGOTE; IN SITU HYBRIDIZATION; MALE; MICE; MICE, KNOCKOUT; MORPHINE; MUTAGENESIS, SITE-DIRECTED; ORGAN SPECIFICITY; OXOTREMORINE; PAIN; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; RESTRICTION MAPPING; SALIVATION; STEM CELLS; TREMOR;

ANIMALIA;

EID: 0033573915     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.4.1692     Document Type: Article

References (38)

1. Brown, J. H. & Taylor, P. (1996) in The Pharmacological Basis of Therapeutics, eds. Hardman, J. G. & Limbird, L. E. (McGraw-Hill, New York), pp. 141-160.
2. Wess, J., Buhl, T., Lambrecht, G. & Mutschler, E. (1990) in Comprehensive Medicinal Chemistry, ed. Emmett, J. C. (Pergamon Press, Oxford), Vol. 3, pp. 423-491.
3. Levine, R. R. & Birdsall, N. J. M., eds. (1995) Life Sci. 56, 801-1050.
4. Levine, R. R. & Birdsall, N. J. M., eds. (1997) Life Sci. 60, 963-1207.
5. Hulme, E. C., Birdsall, N. J. & Buckley, N. J. (1990) Annu. Rev. Pharmacol. Toxicol. 30, 633-673.
6. Caulfield, M. P. (1993) Pharmacol. Ther. 58, 319-379.
7. Wess, J. (1996) Crit. Rev. Neurobiol. 10, 69-99.
8. Levey, A. I. (1993) Life Sci. 52, 441-448.
9. Vilaro, M. T., Mengod, G. & Palacios, J. M. (1993) Prog. Brain Res. 98, 95-101.
10. Wolfe, B. B. & Yasuda, R. P. (1995) Ann. N.Y. Acad. Sci. 757, 186-193.
11. Paszty, C., Mohandas, N., Stevens, M. E., Loring, J. F., Liebhaber, S. A., Brion, C. M. & Rubin, E. M. (1995) Nat. Genet. 11, 33-39.
12. Dörje, F., Wess, J., Lambrecht, G., Tacke, R., Mutschler, E. & Brann, M. R. (1991) J. Pharmacol. Exp. Ther. 256, 727-733.
13. Levey, A. I., Kitt, C. A., Simonds, W. F., Price, D. L. & Brann, M. R. (1991) J. Neurosci. 11, 3218-3226.
14. Yasuda, R. P., Ciesla, W., Flores, L. R., Wall, S. J., Li, M., Satkus, S. A., Weisstein, J. S., Spagnola, B. V. & Wolfe, B. B. (1993) Mol. Pharmacol. 43, 149-157.
15. Gerfen, C. R., Keefe, K. A. & Gauda, E. B. (1995) J. Neurosci. 15, 8167-8176.
16. Buckley, N. J., Bonner, T. I. & Brann, M. R. (1989) J. Neurosci. 8, 4646-4652.
17. König, M., Zimmer, A. M., Steiner, H., Holmes, P. V., Crawley, J. N., Brownstein, M. J. & Zimmer, A. (1996) Nature (London) 383, 535-538.
18. George, R., Haslett, W. L. & Jenden, D. J. (1962) Life Sci. 1, 361-363.
19. Standaert, D. G. & Young, A. B. (1996) in The Pharmacological Basis of Therapeutics, eds. Hardman, J. G. & Limbird, L. E. (McGraw-Hill, New York), pp. 503-519.
20. Ringdahl, B., Roch, M. & Jenden, D. J. (1988) J. Med. Chem. 31, 160-164.
21. Sanchez, C. & Meier, E. (1993) Pharmacol. Toxicol. 72, 262-267.
22. Connor, J. D., Rossi, G. V. & Baker, W. W. (1966) Int. J. Neuropharmacol. 5, 207-216.
23. Connor, J. D., Rossi, G. V. & Baker, W. W. (1966) Exp. Neurol. 14, 371-382.
24. Horst, W. D., Pool, W. R. & Spiegel, H. E. (1973) Eur. J. Pharmacol. 21, 337-342.
25. Korczyn, A. D. & Eshel, Y. (1979) Neuropharmacology 18, 601-603.
26. Quock, R. M. & Lucas, T. S. (1983) Eur. J. Pharmacol. 95, 193-198.
27. Ringdahl, R. & Jenden, D. J. (1987) J. Pharmacol. Exp. Ther. 240, 370-375.
28. Hersch, S. M., Gutekunst, C.-A., Rees, H. D., Heilman, C. J. & Levey, A. I. (1994) J. Neurosci. 14, 3351-3363.
29. Hamilton, S. E., Loose, M. D., Qi, M., Levey, A. I., Hille, B., McKnight, G. S., Idzerda, R. L. & Nathanson, N. M. (1997) Proc. Natl. Acad. Sci. USA 94, 13311-13316.
30. Yaksh, T. L., Dirksen, R. & Harty, G. J. (1985) Eur. J. Pharmacol. 117, 81-88.
31. Green, P. G. & Kitchen, I. (1986) Prog. Neurobiol. 26, 119-146.
32. Hartvig, P., Gillberg, P. G., Gordh, T., Jr. & Post, C. (1989) Trends Pharmacol. Sci. 10, Suppl., 75-79.
33. Iwamoto, E. T. & Marion, L. (1993) J. Pharmacol. Exp. Ther. 266, 329-338.
34. Swedberg, M. D., Sheardown, M. J., Sauerberg, P., Olesen, P. H., Suzdak, P. D., Hansen, K. T., Bymaster, F. P., Ward, J. S., Mitch, C. H., Calligaro, D. O., et al. (1997) J. Pharmacol. Exp. Ther. 281, 876-883.
35. Widman, M., Tucker, S., Brase, D. A. & Dewey, W. L. (1985) Life Sci. 36, 2007-2015.
36. Höglund, A. U. & Baghdoyan, H. A. (1997) J. Pharmacol. Exp. Ther. 281, 470-477.
37. Shannon, H. E., Womer, D. E., Bymaster, F. P., Calligaro, D. O., Delapp, N. W., Mitch, C. H., Ward, J. S., Whitesitt, C. A., Swedberg, M. D., Sheardown, M. J., et al. (1997) Life Sci. 60, 969-976.
38. Myers, R. D. (1980) in Handbook of the Hypothalamus, eds. Morgane, P. J. & Panksepp, J. (Dekker, New York), Vol. 3, Part A, pp. 83-210.